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The Influence of Apathy and Depression on Cognitive Functioning
in Parkinson’s Disease
London C. Butterfield
ABSTRACT
Depression and apathy are two of the most common psychiatric symptoms in
Parkinson’s disease (PD) with prevalence estimates at higher rates than in medical
populations with similar levels of disability. Several studies have provided evidence to
suggest that apathy and depression are independent clinical phenomena that may
differentially affect cognition. Recent research suggests that apathy may account for
cognitive deficits over and above that of depression, especially in the domain of
executive functioning. However, few studies have examined the independent influence of
depression and apathy on cognitive abilities in patients diagnosed with PD using sensitive
measures of specific cognitive domains. In addition, many have used measures of apathy
and/or depression with symptom overlap, which may not adequately measure symptoms
unique to the target construct.
The purpose of this study was to examine the independent influences of
symptoms of depression and apathy on memory and executive functioning in patients
diagnosed with PD using severity scales specifically designed to provide greater
discrimination between symptoms. Depression severity was assessed using items that do
not overlap with apathy symptoms or with somatic symptoms of PD itself. Apathy was
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measured using a scale previously shown to have little overlap with depressive
symptoms.
Results revealed that apathy, but not depression, was significantly associated with
executive functioning. In contrast, immediate memory was significantly associated with
both apathy and depression. However, apathy accounted for added variance in memory
scores when controlling for depression with marginal significance. When controlling for
age, although less clear, these patterns remained.
Differentiation of apathy and depression and understanding their independent
effects on cognitive functioning have several implications both for clinical intervention
and for scientific investigation. Apathy not only has a negative impact on cognitive
functioning, but also on daily functioning and caregiver burden/distress. Secondly, it has
been associated with increased mortality as it may interfere with medication compliance.
If appropriately identified, preliminary research suggests that symptoms of apathy may be
medically treated independently of depressive symptoms. Distinguishing apathy and
depression has robust implications for the advancement of psychological science, patient
care, and for enhancing quality of life in patients and caregivers.
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1. Introduction
Parkinson’s Disease (PD), a chronic and degenerative neurological disorder,
affects approximately one million people over the age of fifty in the United States alone.
While motor dysfunction is most apparent in PD, psychiatric symptoms have been
reported to occur in as many as 90% of PD patients (Starkstein, Mayberg, Leiguarda,
Preziosi, and Robinson, 1992b), with depression being the most common symptom.
Prevalence estimates of clinically elevated depression average at around 40% in this
population (Cummings, 1992), compared to 4-6% of older adults in the general
population (Steffens et al., 2000). Apathy, a symptom related to motivational and selfinitiation impairment, is also elevated in PD and other disorders involving the basal
ganglia, with an average estimated prevalence of 40.6% (van Reekum, Stuss, and
Ostrander, 2005). Again, this is higher than found in the general population, where the
prevalence of clinically elevated apathy is estimated at 6.8% in older adults (Onyike et
al., 2007). Psychiatric symptoms may negatively impact several patient variables,
including daily functioning, cognitive functioning, and quality of life and may
additionally impact caregiver burden and distress (Shrag, Jahanshahi, and Quinn, 2000;
Chen, 2004; Keranen et al., 2003; Gote, 1999).
Several studies suggest that apathy and depression are independent clinical
phenomena that negatively affect memory, language, and executive functioning
(Starkstein et al., 1992a; Pluck and Brown, 2002; Isella et al, 2002; Feil, Razani, Boone,
1

and Lesser, 2003). Recent research suggests that apathy may account for cognitive
deficits over and above that of depression. Few studies have investigated the independent
influence of depression and apathy on cognitive abilities in patients diagnosed with PD.
Further, the few studies that have examined these relationships have used simple
screening measures of global cognitive ability that are insensitive to specific cognitive
domains.
The present study will attempt to enhance our understanding of the independent
influences of depression and apathy on memory and executive functioning in patients
diagnosed with PD using sensitive and more specific cognitive measures. Hierarchical
regression will allow for examination of the influence of depression on cognitive
performance while controlling for the independent influence of apathy, and vice versa.
Before providing a detailed account of the methodological plan for the present study, an
introduction to PD and a review of the literature that has examined the relationships
between depression, apathy, and cognition in this population is provided.

Parkinson’s Disease
First described as the “shaking palsy” by James Parkinson in 1817 (Parkinson,
1817), Parkinson’s Disease (PD) has since become prevalent worldwide, occurring in an
estimated 1% of people over the age of fifty, or about one million people, in the United
States alone (Stern, 1993). Most cases of PD present after the age of 50, with a mean age
of onset at 55 to 60 years (Mackin, 2000; Stern, 1993). Few cases, if any, appear after the
age of 80 (Mackin, 2000). Although the exact cause of PD remains unknown, there are
2

several theorized causes of the disorder. These include toxic exposures (environmental,
occupational, or drug induced), oxidative stress, and genetics. Most cases of PD are
considered idiopathic, or of unknown cause.
PD is a chronic, progressive neurodegenerative disorder marked by slow
degeneration of dopaminergic neurons primarily in the substantia nigra. The depletion of
dopamine interferes largely with the nigrostriatal pathway of the basal ganglia, a system
largely implicated in the production of movement and coordinated muscle control (Gibb,
1992). PD patients have lost at least 60-70% of their dopamine-producing cells by the
time motor symptoms appear (Fearnley and Lees, 1991). Although dopamine and the
nigrostriatal pathway are primarily affected, there is evidence of disruption to other brain
regions (e.g. locus ceoruleus, specific reticular nuclei) and circuits (e.g., mesolimbic
pathway) as well, resulting in noradrenergic, serotonergic, and cholinergic abnormalities
of the basal ganglia (Lang and Lozano, 1998, Mackin, 2000). Decreased dopamine in the
mesolimbic pathway, a system related to reward sensitivity, may contribute to psychiatric
symptoms of depression and apathy (Lieberman, 2006; Fibiger, 1984).
The classic triad of motor signs in PD include resting tremor, rigidity, and
bradykinesia/akinesia (Lang and Lozano, 1998). Resting tremor is the most common and
identifiable sign of disease, being the initial complaint in approximately 70% to 75% of
cases (Stern, 1993). Tremors often occur in the hands, fingers, forearms, foot, mouth, or
chin, and take place when the limbs are at rest. When the patient voluntarily initiates
movement, however, the tremor subsides. Rigidity refers to muscle stiffness that occurs,
also called cogwheeling, which can result in muscle pain or discomfort during movement.
3

Bradykinesia refers to the slowness of voluntary movement, such as standing up,
walking, and sitting down, that occurs because of delayed transmission signals from the
brain to the muscles. Parkinson’s gait, characterized by a shortened stride, and shuffling
steps, is a common feature. Other primary motor symptoms include postural instability,
or poor balance, and other coordination impairment. In later stages of the disease,
akinesia (lack of voluntary movement), festination (more severe and abnormal gait
pattern), hypophonia (voice weakness), dysarthria (speech impairment), chewing and
swallowing difficulties, as well as drooling can occur (Mackin, 2000).
Symptom progression varies by individual but typically progresses over a period
of 10 to 20 years (Langston, 1990). Progression can be divided into three states: early,
nonfluctuating, and fluctuating (Bradley, 1996). Patients in the early stage of disease may
be monosymptomatic or have multiple mild symptoms that do not need medication
management, with symptoms typically presenting unilaterally. In the nonfluctuating
stage, symptoms become disabling and may not respond to first-line therapy. Once
patients have reached the fluctuating stage of disease, continual progression of symptoms
has occurred and control over symptoms fluctuates. Postural instability and gait
disturbance is increased and function has become more impaired despite therapy.
While motor dysfunction is typically the most apparent in PD, psychiatric
symptoms are also prevalent and have been reported to occur in as many as 90% of PD
patients (Starkstein et al., 1992b). Depression is the most common psychiatric symptom
with apathy, anxiety, sleep disturbance, and hallucinations occurring at high rates as well.
Hallucinations are commonly attributable to anti-Parkinson’s medications and are
4

typically visual and benign in nature (Mackin, 2000). Psychiatric symptoms have a
significant negative impact on daily functioning, quality of life, cognitive functioning and
caregiver burden and distress (Shrag, Jahanshahi, and Quinn, 2000; Chen, 2004; Keranen
et al., 2003).
Mental decline affects up to 90% of patients (Pirozzolo, Hansch, Mortimer,
Webster, and Kuskowski, 1982). In contrast, severe cognitive impairment is less frequent,
affecting approximately 25% of patients, as most symptoms are subtle and do not
interfere significantly with everyday activities (Mayeux et al., 1990; Stocchi and Brusa,
2000). Characteristic cognitive changes in PD include impairment in attention,
abstraction and reasoning, visuospatial abilities, executive functions, and memory
(Stocchi and Brusa, 2000).
The greatest area of difficulty for PD patients involves executive functions. These
mental operations are involved in adapting to novel situations, problem solving, planning,
generating new concepts and elaborating cognitive and behavioral responses to
environmental situations (Stocchi and Brusa, 2000). Tests commonly used to evaluate
executive functions include Trail Making Test, Stroop test, letter fluency (e.g., FAS),
Tower of London for problem solving, and Wisconsin Card Sorting Test (WCST).
Regarding memory disturbance, impairment may be found in working memory,
immediate recall, and delayed recall. Research has shown that PD patients have more
pronounced impairments on immediate memory tasks compared to delayed memory tasks
(Sagar, Cohen, Sullivan, Corkin, and Growdon, 1988). The ability to register, store, and
consolidate data appears preserved; however, the recall deficit is due to impairment in the
5

ability to activate processes that are associated with the functional use of memory stores
(Stocchi and Brusa, 2000). Long-term memory is impaired due to a decrease in
attentional resources rather than decreased storage (Pillon, Dubois, and Agid, 1996). This
decreased attentional capacity interferes with organizing material to be remembered,
temporal ordering, and memory retrieval strategies (Harrington, Haaland, Yeo, and
Marder, 1990).
Visuospatial disturbance may also be present in PD, but results from a decrease in
processing resources rather than from a specific visuospatial dysfunction (Brown and
Marsden, 1986).

Depression in PD
Depression is the most common psychiatric symptom in PD, and is found at
higher rates in this population than in medical populations with similar levels of
disability, such as rheumatoid arthritis (Brown and Jahanshahi, 1995; Cummings and
Masterman, 1999; Zesiewicz and Hauser, 2000). Prevalence estimates of depression in
PD range from 3 to 70% (Cummings, 1992; Burn, 2002), although most estimates are
closer to 40%, with just over half meeting criteria for major depression and just under
half meeting criteria for dysthymia or minor depression (Cummings, 1992). The
variability reported across studies is partially dependent upon heterogeneous samples
used (e.g., hospitalized, community-based) as well as the research tools used to measure
depression, with lower rates generally reported in studies that include diagnostic criteria
and scripted interviews (e.g., Structure Clinical Interview for the DSM-IV, SCID)
6

compared to studies using rating scales (e.g., Beck Depression Inventory, BDI; Beck et
al., 1961, 1996) (Edwards et al., 2002).
Symptom overlap also contributes to the variability in prevalence estimates.
Symptoms of depression, primarily somatic [e.g., psychomotor retardation, flat affect,
“masked facies” (reduced facial expression of emotion), anergia], often overlap with core
features of PD (Edwards et al., 2002), and may lead to an over-estimation of depression
in patient samples. Most prevalence studies in research centers find depression in 40% to
50% of PD patients (Edwards et al., 2002; Mayeux, Stern, Williams, Sano, and Cote,
1986; der Gotham, Brown, and Marsden, 1986), with half meeting criteria for major
depressive disorder (MDD) and half meeting criteria for dysthymia or minor depression
(Starkstein, Preziosi, Bolduc, and Robinson, 1990b; Brown and MacCarthy, 1990).
Research studies that use diagnostic criteria in identifying levels of depression
typically define major and minor depression using criteria of the Diagnostic and
Statistical Manual of Mental Disorders (DSM). According to the most recent edition of
the DSM (i.e., DSM-IV-TR; APA, 2000) major depression is defined by the presence of
five or more of the following symptoms during the same two-week period and
representing a change from previous functioning, with at least one of the symptoms being
(1) or (2):
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)

depressed mood
markedly diminished interest or pleasure in all, or almost all, activities
significant weight loss when not dieting or weight gain, or decrease in appetite
insomnia or hypersomnia
psychomotor agitation or retardation
fatigue or loss of energy
feelings of worthlessness or excessive or inappropriate guilt
diminished ability to think or concentrate, or indecisiveness
7

(9) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation
without a specific plan, or a suicide attempt or a specific plan for committing
suicide
As for minor depression, depressive symptoms must be present for at least two weeks but
fewer than five symptoms are required.
Depression in PD differs from idiopathic depression in that PD patients
experience relatively increased levels of dysphoria and pessimism about the future,
irritability, sadness and suicidal ideation, while guilt, self-blame, feelings of failure, and
completed suicide are less common (Brown, MacCarthy, Der Gotham, and Marsden,
1988; Taylor, Saint-Cyr, Lang, and Kenny, 1986). Depression in PD is an important issue
to address as these patients have more rapid disease progression, increased cognitive
decline, increased functional disability, and poorer quality of life than PD patients
without depression (Sano et al., 1989; Starkstein et al., 1992b; Cole et al., 1996).
It remains unclear whether PD patients have a biological vulnerability to
depression, or whether depression is a reaction to disability. In support of the former
hypothesis, Schuurman et al. (2002) found an increased incidence of PD in patients with
a prior history of depression, perhaps reflecting a biological risk factor for depression in
still symptom-free, preclinical stages of PD. Other studies also support that symptoms of
depression often precede motor symptoms and the diagnosis of PD (Brown and
Jahanshahi, 1995; Cummings and Masterman, 1999).
Hypotheses for the etiology of depression in PD tend to favor neurodegeneration
as the primary source (Tandberg, Larsen, Aarsland, Laake, and Cummings, 1997;
Cummings and Masterman, 1999). Evidence exists to suggest that dopamine, serotonin,
8

and norepinephrine play an important role in depression (e.g., Cummings and
Masterman, 1999; Zesiewicz, Gold, Chari, and Hauser, 1999). PD patients who
experience the ‘on-off’ phenomenon (i.e., fluctuations in motor symptoms that are
associated with response to medication), for instance, complain of a greater level of
depression during the ‘off’ state, when dopamine levels are low and motor symptoms are
more severe (Menza, Sage, Marshall, Cody, and Duvoisin, 1990). Several studies have
found lower levels of 5-hydroxyindoleacetic acid, the principal metabolite of serotonin,
in PD patients with depression as compared to PD patients without depression (e.g.,
Sjostrom and Ross, 1973; Ashcroft et al., 1966). In addition, norepinephrine levels are
more markedly decreased in PD patients with depression as compared to those without
depression (Lieberman, 2006). In PD, each of these neurotransmitter systems is disrupted
and may underlie the high rates of depression as well as the cognitive impairment that is
experienced.

Depression and Cognition in PD
Prior studies of PD patients indicate that depression has an adverse impact on
cognitive functioning and may serve as a risk factor for cognitive decline. One
epidemiologic study revealed that depression was a significant and independent predictor
of incident dementia in PD (Stern, Marder, Tang, and Mayeax, 1993). In the first
longitudinal study to investigate the influence of depression on cognitive decline in PD,
Starkstein and colleagues (Starkstein, Bolduc, Mayberg, Preziosi, and Robinson, 1990a)
found that patients who were depressed at baseline showed significantly greater decline
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in global cognitive functioning (i.e., MMSE score) at a three- to four-year follow-up as
compared to PD patients who were not depressed at baseline.
In a later study, Starkstein et al. (1992b) divided depressed PD patients into two
groups: (1) those meeting DSM-III criteria for major depression, and (2) those meeting
DSM-III criteria for minor depression. At one year follow-up, patients with major
depression at baseline evaluation showed significantly greater decline in global cognitive
functioning than those with minor depression or no depression at baseline. Patients were
matched for duration of illness and disability severity in order to control for the
possibility that these disease factors, rather than depression, were accounting for the
cognitive declines.
In a series of studies, Tröster and colleagues built upon the literature to further
investigate the relationship between depression and cognition in PD (i.e., Tröster, 1995a;
Tröster, 1995b; Norman, Tröster, Fields, and Brooks, 2002). First, they compared PD
patients with depression (PDD) and without depression (PDN) to normal control (NC)
subjects matched for age, education, gender, disease duration, age of disease onset, and
disease severity to find that both PD groups (PDD and PDN) showed greater impairment
on a screening measure of global cognitive ability (i.e., Mattis Dementia Rating Scale,
DRS), with particular impairments on Conceptualization and Initiation/Perseveration
subscales, as compared to NC subjects. PDD patients performed significantly worse than
PDN patients (Tröster, 1995a). To follow, they used a more extensive battery of
neurocognitive assessments to evaluate the qualitative difference in cognitive abilities
between PDD and PDN patients (Tröster, 1995b). Results suggested that depression
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exacerbated some memory and language impairments previously associated with PD and
that depression influences the severity rather than the quality, or pattern, of cognitive
impairment in PD.
In a third study, these researchers (Norman et al., 2002) added a comparison
group of subjects with depression but without PD (D) that would allow them to determine
whether the previously identified cognitive impairments were due to a combined effect of
PD and depression or to depression alone. This is important since the same frontal
metabolic changes that may be strongly related to cognitive impairment are found in
depressed individuals regardless of having a PD diagnosis (Dolan et al., 1994; Norman et
al., 2002). Results revealed poorer overall cognitive functioning (i.e., DRS total) in both
PD groups (PDD and PDN) as compared to non-PD groups (NC and D). Interestingly,
both depressed groups (D and PDD) performed more poorly on the Memory subscale as
compared to PDN patients, suggesting that the memory impairment found in PDD
patients may be a result of depression alone as opposed to a combined effect of
depression and PD.
In a similar study, Kuzis and colleagues (1997) found that patients with
depression, with or without PD, showed significantly greater impairment on verbal
executive (fluency) ability and auditory attention as compared to those who were nondepressed (PDN and NC). PDD patients were significantly more impaired than the other
three groups on concept formation (i.e., Raven Progressive Matrices) and set shifting
(Wisconsin Card Sorting Test), a measure of executive functioning. Further, no
differences in cognitive performance were found between PDN patients and NC subjects.
11

In sum, the presence of depression in PD may exacerbate existing cognitive
deficits on tasks such as concept formation, memory, language, and executive
functioning.

Apathy in PD
In contrast to depression, apathy and abulia (a more severe form of apathy) are
not characterized by anhedonia, hopelessness, or low mood; rather, they are characterized
by isolated lack of motivation and self-initiative (Shrag, 2004). The study of apathy as a
neuropsychiatric construct in neurological disorders has only recently begun, with its
initiation in 1990 (Marin, 1990; Marin, Biedryzycki, and Firinciogullari, 1990; Burns,
Folstein, Brandt, and Folstein, 1990; Robinson and Starkstein, 1990). Apathy, derived
from the Greek term pathos, meaning passions, is conventionally defined as the absence
or lack of emotion, feeling, interest, or concern (Marin, 1990, 1991). Clinically, this
definition of apathy is lacking and fails to address a variety of other psychological
features. Individuals with frontal lobe injury, for instance, may be experiencing apathy
along with some other intense emotion, such as irritability or euphoria. Similarly, a
depressed individual may appear to be “lacking emotion, interest, and concern,” while
s/he is indeed experiencing severe internal emotional pain.
Marin provided a more clinically appropriate definition of apathy as a primary
motivational impairment that is, importantly, not secondary to cognitive or intellectual
impairment, emotional distress, or diminished level of consciousness (drowsiness and/or
diminished attention) (Marin, 1990, 1991). One who meets this definition of apathy may
12

be regarded as having apathy syndrome. Loss of motivation due to disturbance of intellect
(e.g., dementia), emotion (e.g., depression), or level of consciousness (e.g., delirium)
defines the symptom of apathy (Marin, 1991). Motivation itself refers to characteristics
and determinants of goal-directed behavior (Marin, 1991).
Stuss et al. (2000) revised the definition of apathy as “an absence of
responsiveness to stimuli as demonstrated by a lack of self-initiated action,” suggesting
that this definition would allow for objective behavioral measurement. They proposed
that previous conceptualizations of apathy as a lack of motivation were flawed in that
assessment of inner urges is problematic and necessitates inference based on observations
of affect and behavior.
Marin (1991) proposed that symptoms of apathy can be classified into three
concomitants of goal-directed behavior: “emotional” (i.e., lack of emotional
responsiveness; lack of excitement or emotional intensity; unchanging affect),
“cognitive” (i.e., lack of interest; lack of concern about one’s personal problems;
diminished importance or value attributed to various goal-related domains), and “(overt)
behavioral” (i.e., lack of effort; lack of initiative or perseverance; compliance or
dependence on others to structure activity).
Since apathy itself may be considered as behavioral (i.e., an observable state),
Levy and Dubois (2005) refer to the third domain as an “auto-activation deficit” that is
not primarily due to an “emotional” or “cognitive” deficit and can be reversed by external
stimulation. They proposed that the three concomitants of apathy (i.e., emotionalaffective, cognitive, and auto-activation of behavior) may each be explained by
13

disruption to three underlying mechanisms and their associative basal ganglia subregions:
orbital-medial, dorsal-lateral, and dorsal-medial streams. Amotivational symptoms are
reported in several cases of frontal impairment (i.e., stroke, degeneration, head injury)
and frontal-subcortical limbic dysfunction (i.e., PD, AD, stroke) and may underlie
associated executive functioning deficits (Isella et al., 2002).
PD is a classic example of a subcortical disorder in which apathy is a wellrecognized feature (Isella et al., 2002; Pluck and Brown, 2002; Aarsland et al., 1999;
Starkstein et al., 1993, 1995; Marsden and Parkes, 1977) and it is hypothesized that
nigrostriatal dopamine depletion in PD may contribute (Levy and Dubois, 2005).
Clinically significant apathetic symptoms are present in approximately 40% to 45% of
PD patients (Isella et al., 2002; Starkstein et al., 1992a), compared to 6.8% in healthy
older adults (Onyike et al., 2007), with apathetic syndromes (not secondary to depression,
delirium, or dementia) present in about 12% of PD patients (Starkstein et al., 1992a).
Apathy appears to be a result of neurological disturbance rather than a result of
psychosocial limitations of physical disability. Pluck and Brown (2002) showed that,
while PD and osteoarthritis are similarly chronic, progressive conditions that cause
significant levels of disablement, significant levels of apathy were found in PD patients,
but no evidence of apathy was present in osteoarthritic patients. Isella et al. (2002)
showed that groups of patients with low, moderate, and high levels of apathy did not
differ from each other in PD duration or severity, suggesting that apathy unlikely
represents a simple reaction to disability. These findings together have been provided as
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support for the view that apathy is not a psychological response to physical disability, but
rather a neurobiological feature of PD.
Some hypotheses suggest that apathy and depression are related to distinct
neurological circuits, with depression being secondary to dysfunction of brainstem
serotoninergic neurons (i.e., raphe nuclei) that project to limbic areas, and apathy derived
from the noradrenergic deficit at the locus coeruleus (connected with cortical and
subcortical structures) (Starkstein et al., 1992a; Mayeux et al., 1987). Marin (1990, 1991;
also see Isella et al., 2002) suggested that a frontal-subcortical limbic circuit (i.e.,
prefrontal cortex, anterior cingulate gyrus, entorhinal cortex, and the basal ganglia),
which seems to play a central role in conveying emotionally relevant information,
elaborating drive, and in planning and monitoring motivated behavior, may mediate the
association found between apathy and executive functioning. Dysfunction of this region
may result in executive deficits, amotivation, and/or of the capacity to organize goaldirected behavior.

Apathy and Depression: Independent Clinical Phenomena
While certain symptoms may be shared among apathy and depression (i.e.,
diminished interest, psychomotor retardation, fatigue/hypersomnia, lack of insight),
several researchers have suggested that certain symptoms are unique to apathy (i.e.,
blunted affect, indifference, low social engagement, diminished initiation, poor
persistence) and certain symptoms are unique to depression (i.e., dysphoria, suicidal
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ideation, self-criticism, feelings of guilt, pessimism, hopelessness, sleep disturbance)
(Marin et al., 1993, Marin 1990, Landes et al., 2001).
Various methods have been employed to examine the discriminability of apathy
and depression as independent clinical phenomena. Depression is a syndrome in which
apathy may be present, in which case it may be termed apathetic depression (Marin,
1990). In this instance, a depressed person’s apathy may be described by a person’s
inactivity and expressed loss of interest in usual activities. However, there are several
instances in which depression may exist in the absence of apathy. In the case of the
depressed person who demonstrates deliberate and active avoidant behavior, or in the
extreme case of suicide, clearly apathy (which describes passivity or a lack of goaldirected behavior) is not an accurate descriptor (Marin, 1990). Further, apathy may exist
as a distinct syndrome, in which, by definition, there is absence of emotional distress.
Weitzner, Kanfer, and Booth-Jones (2005) described four cases of pituitary
disease patients who appeared to be suffering from depression, but when diagnosed and
treated for depression they showed little response to treatment. When the patients were
asked about their mood, all stated that they were experiencing chronic fatigue and lack of
motivation, and were not feeling depressed. When the diagnosis of apathy syndrome was
considered and treatment with methylphenidate was implemented, the patients’ condition
improved subjectively and on objective cognitive tasks (i.e., verbal and nonverbal
learning, several executive tasks, and psychomotor speed).
One method of distinguishing apathy and depression is to evaluate the rates and
relationships between apathy and depression in different diagnostic groups. Marin et al.
16

(Marin, Firinciogullari, and Biedrzycki, 1994) evaluated patients diagnosed with
Alzheimer’s disease (AD), stroke, and major depression using the Apathy Evaluation
Scale (AES; Marin, Biedrzycki, and Firinciogullari, 1991) and the Hamilton Depression
Rating Scale (HDRS; Hamilton, 1960). Despite the fact that there was a significant
correlation found between apathy and depression scores when all five diagnostic groups
were included in the analysis, proportions of patients with apathy and/or depression
varied considerably among groups. Specifically, AD patients showed high levels of
apathy and low levels of depression, left hemisphere stroke patients and patients with
major depression showed high levels of depression and low levels of apathy, and patients
with right hemisphere stroke showed equivalent levels of apathy and depression. The
authors used this evidence to suggest that apathy and depression are clinically distinct
neuropsychiatric syndromes.
Levy et al. (1998) evaluated whether apathy and depression may be produced by
different neuroanatomical or neurochemical substrates by evaluating these two symptoms
in different diagnostic groups, including patients diagnosed with PD, AD, frontotemporal
dementia (FTD), progressive supranuclear palsy (PSP) and Huntington’s disease (HD).
Firstly, apathy and depression were not correlated in the combined sample. Secondly, the
frequency of apathy and depression significantly varied across groups with a large
number of AD, FTD, and PSP patients having apathy without depression, and many PD
and HD patients having depression without apathy. This disparity was especially notable
in patients with PD and PSP. Few PD patients presented with apathy alone compared to
those who had depression with or without apathy, and few PSP patients presented with
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depression, but a high frequency of PSP patients presented with apathy. These findings
suggest that the relationship between apathy and depression appears to be diseasespecific.
Landes et al. (2005) explored the differential relationship of apathy, dysphoria,
and depression with other clinical variables (i.e., stage of disease, cognitive impairment,
and functional impairment) in patients diagnosed with Alzheimer’s disease to provide
support for the differentiation of apathy and mood disturbance. Their analyses revealed
that apathy occurs more frequently than dysphoria in AD. Apathy was strongly related to
disease severity, cognitive impairment, activities of daily living, while dysphoria was
weakly related or unrelated to these variables. Landes et al. (2005) provided these results
as evidence for the importance of a syndrome-based approach, with emphasis on the
importance of distinguishing dysphoria from apathy syndrome.

Apathy, Depression and Cognition
Another method of dissociating apathy and depression as distinct constructs is to
evaluate their independent influences on cognitive functioning. Some studies have
revealed an effect of apathy on cognitive functioning in PD that is distinct from that of
depression. Starkstein and colleagues (2005) demonstrated a significant association of
apathy and global cognitive abilities, as measured with the Mini Mental Status Exam
(MMSE), but no significant association of depression and global cognitive abilities. In
their sample of Alzheimer’s disease patients, those with apathy had significantly more
severe cognitive deficits than those without apathy. Levy (1998) also found that apathy
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correlated significantly with increased cognitive impairment as measured with the MMSE
whereas depression did not.
To investigate depression, apathy, and cognition in a sample of patients diagnosed
with Alzheimer’s disease, Kusiz and colleagues (1999) classified patients into four
groups: (1) depression-only (without apathy); (2) apathy-only (without depression); (3)
both depression and apathy; and (4) controls with neither depression nor apathy. Patients
meeting the DSM-IV criteria for major depression or dysthymia were considered
depressed, whereas patients scoring more than two standard deviations above the mean
apathy scale score were considered apathetic. Using ANOVA and post hoc t-tests to
compare groups, Kusiz and colleagues found that patients with apathy only (without
depression) had significantly lower scores on verbal memory and confrontational naming
compared to patients without apathy (depression-only and control). Patients with apathy
only (without depression) and patients with both apathy and depression had significantly
lower scores on a dexterity task as compared to patients with neither apathy nor
depression (controls) and had significantly lower scores on two executive measures as
compared to patients without apathy (depression-only and control). Overall, their results
suggest that memory and executive deficits were associated with apathy rather than
depression.
In a sample of non-demented older adults diagnosed with major depressive
disorder (MDD), Feil and colleagues (2003) examined apathy, depression, and cognitive
performance using correlations and individual stepwise regression analyses. Results of
correlational analyses revealed significant correlations between apathy and two cognitive
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measures: nonverbal executive (WCST-Other Responses) and processing speed (Stroop
B). Near-significant relationships were found between apathy and two verbal executive
measures (FAS and Stroop C). Depression was significantly correlated with two
information processing speed measures (Stroop A and Stroop B) and near-significant
relationships were found between depression and verbal executive performance (Stroop
C).
Individual stepwise regression (i.e., entry of the independent variables, IVs, is
determined by the statistical software based on the magnitude of correlations with the
dependent variable) was performed on the four cognitive measures that significantly
correlated with apathy (i.e., Stroop B, Stroop C, FAS, and WCST) to determine whether
apathy uniquely accounted for test score variance over and above that accounted for by
depression, health status, age, and education. Regression analyses on the four IVs
revealed that apathy alone accounted for a significant amount of test score variance on a
nonverbal executive task (WCST; R2 = 0.13) and that apathy plus demographic variables
together accounted for a significant amount of variance on two verbal executive measures
(FAS and Stroop C). Specifically, education was the best predictor of one verbal
executive measure (FAS; R2 = 0.074), followed by apathy (R2 = 0.070). Age was the best
predictor of the second verbal executive measure (Stroop C; R2 = 0.171), followed by
apathy (R2 = 0.100). Apathy, depression, and age together accounted for a significant
amount of variance on a processing speed task (total R2 = 0.308). Specifically, depression
was the best predictor of processing speed (Stroop B; R2 = 0.219), followed by age (R2 =
0.046), then apathy (R2 = 0.043). Overall, both apathy and depression were associated
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with some cognitive variables, but apathy was a greater influence on executive
functioning than was depression severity.

Apathy, Depression and Cognition in PD
Only four studies have investigated depression, apathy, and cognition in a sample
of patients diagnosed with PD using a more extensive battery of neurocognitive
assessments (Starkstein et al., 1992a; Isella et al., 2002; Pluck and Brown, 2002;
Aarsland et al., 1999). All four studies revealed a significant relationship between apathy
and cognitive impairment, particularly in executive functioning.
Starkstein and colleagues (1992a) examined correlates of apathy, depression, and
cognition by comparing PD patients with apathy only, depression only, apathy plus
comorbid depression, and neither depression nor apathy (control subjects). This research
team found that the patients with apathy (with or without depression) showed
significantly more deficits on time-dependent executive tasks (specifically, poorer verbal
fluency/executive as measured by FAS and slower performance on Trail Making Test B),
whereas depressed patients showed significantly more deficits in an untimed executive
task (i.e., Wisconsin Card Sorting Task, WCST). Both apathy and depression were
significantly associated with impaired episodic verbal memory.
Aarsland and colleagues (1999) found a significant correlation between apathy
and number of errors on the Stroop test, a measure of executive functioning. This
relationship was not found between depression and cognition or between apathy and
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depression, suggesting that the relationship between apathy and cognitive decline is not
due to depression.
Isella and colleagues (2002) compared PD patients with low, moderate, and high
levels of apathy and found a clear association between apathy and executive functioning,
with the high-apathy group showing significantly greater impairment in executive
functioning [i.e., Executive Interview (EXIT), letter fluency and category fluency]
compared to the other two groups. Depression was not significantly correlated with
apathy or any cognitive abilities measured. The research group did not, however,
examine the independent influence of depression on cognitive abilities.
Pluck and Brown (2002) found similar results showing that apathy, but not
depression, was related to deficits in global cognitive ability (especially on the memory
and language subscales) and on three measures of executive functioning (i.e., category
fluency, Stroop Color-Word test, and WCST). A series of exploratory regression analyses
demonstrated that, while none of the clinical or demographic variables (age, sex,
education, duration of illness, Hoehn and Yahr stage or Schwab and England score)
predicted apathy ratings, category fluency and Stroop Interference were the best
predictors of apathy scores.
Overall, these studies suggest that apathy and depression are independent clinical
phenomena that negatively affect memory, language, and executive functioning. Further,
they suggest that apathy may account for cognitive deficits over and above that of
depression, particularly in the cognitive domain of executive functioning.
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Limitations of Previous Research
Although several studies have examined the relationships between apathy,
depression, and cognitive functioning in patients with neurological conditions (e.g.,
Alzheimer’s disease, Frontotemporal Dementia, and Huntington’s disease), only four
have examined specific domains of neurocognitive impairment in patients diagnosed with
PD. The few studies have examined these relationships are limited in several ways.
First, many have used measures of apathy and/or depression with questionable
ability to measure symptoms unique to the target construct. Symptom overlap hinders
discriminability among constructs. For instance, Starkstein et al. (1992a) used the
Hamilton Depression Rating Scale (HDRS), a widely used measure that has been accused
of being a weak index of depressive severity due to poor content validity and a
multidimensional factor structure (Gibbons, Clark, and Kupfer, 1993; Bagby, Ryder,
Schuller, and Marshall, 2004). Aarsland et al. (1999) used the Neuropsychiatric Inventory
(NPI; Cummings et al., 1994), a measure commonly used in dementia to measure
dysphoria, apathy, and anxiety, among several other neuropsychiatric disturbances.
Factor analysis of the NPI showed that apathy and anxiety existed together on one factor,
revealing that the NPI measures shared symptoms of apathy and anxiety.
Pluck and Brown (2002) measured depressive symptoms using the Beck
Depression Inventory (BDI; Beck, Ward, Mendelson, et al., 1961), which includes
numerous somatic items that overlap with symptoms of PD itself. Use of such measures
may artificially inflate depressive symptom severity in medical populations (Taylor,
Lovibond, Nicholas, Cayley, and Wilson, 2005).
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In the present study, the Apathy Evaluation Scale – self-rating form (AES-S;
Marin, 1991), a scale specifically designed to discriminate apathy from depression, will
be used to measure apathetic symptoms. The self-rating version of the AES was chosen
based on the consideration that motivation is an internal state that informants may not be
able to adequately assess. Further, informants may have difficulty distinguishing between
emotional symptoms of apathy (i.e., unchanging affect) and “masked facies,” a common
deficit in PD patients that refers to decreased facial expression. A multitrait-multimethod
matrix procedure was used to support the convergent validity and discriminant validity of
the AES-S (Marin, 1991). While apathy scales, such as the AES, have been designed to
discriminate between apathy and depression, no depression scales have been developed
with the intent to eliminate symptoms that overlap with apathy.
The present study will utilize select items from the Beck Depression Inventory –
II (BDI-II) in an attempt to assess a continuum of depressive symptoms that do not
overlap with apathy symptoms or with somatic symptoms of PD itself. A total of 13
items will be retained from the BDI-II that assess the same content domains as identified
in cognitive/affective scale of the BDI-I. Use of the full BDI-II is not ideal for a PD
population since many of these patients may experience somatic symptoms that are
unrelated to depression (Taylor et al., 2005). Items corresponding to the
cognitive/affective scale of the BDI-I will be retained (e.g., sadness, pessimism, sense of
failure, etc.) with the exception of the item related to lack of interest due to its possible
overlap with apathy. Items that correspond to the somatic/behavior scale of the Beck
Depression Inventory – I (BDI-I) (e.g., sleep disturbance, appetite, tiredness/fatigability,
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etc.) will be eliminated to protect against artificial inflation of depressive symptom
severity.
As mentioned above, most studies investigating the relationships between
depression, apathy, and cognition have used measures of global cognitive ability (e.g.,
MMSE), rather than measures assessing specific cognitive domains. The present study
will examine verbal memory and executive functioning, two cognitive abilities that have
shown to be associated with depression, apathy, and PD.
Lastly, most of the studies described above have used correlational analyses and
ANOVAs with post-hoc comparisons, with the exception of two (Pluck and Brown,
2002; Feil et al., 2003). While such designs are elegant in their ability to evaluate
emotional and cognitive differences among groups of individuals, they do not provide
information regarding the degree to which apathy or depression influences cognition over
and above the other. In the present study, hierarchical regression analyses will allow for
investigation of the influence of depression on cognitive performance while controlling
for the independent influence of apathy, and vice versa.

Purpose of the Proposed Study
The purpose of this study is to examine the independent influence of depression and
apathy on cognitive functioning (specifically, memory and executive functioning) in PD
patients. Depression is the most common psychiatric symptom in PD and has been shown
to be associated with cognitive deficits. Apathy, a symptom related to motivational and
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self-initiation impairment, is also prevalent in PD and has gained recent attention in this
population.
Several studies have demonstrated evidence to suggest that apathy and depression
are independent clinical phenomena. Recent research suggests that apathy may account
for cognitive deficits over and above that of depression. However, few studies have
examined the independent influence of depression and apathy on cognitive abilities in
patients diagnosed with PD. The majority of these studies have used simple screening
measures of global cognitive ability that are insensitive to specific cognitive abilities,
such as executive functioning and verbal memory. In addition, only two studies have
examined these relationships using hierarchical regression, only one of which was in a
PD population. Hierarchical regression allows us to pit apathy and depression against
each other in a test that provides an estimate of the degree of influence that depression
has on cognitive performance while controlling for the independent influence of apathy,
and vice versa

Hypotheses/Predictions
It is hypothesized that increased levels of depression and apathy will be associated
with decreased performance on measures of executive and memory abilities. This
hypothesis will be examined in two ways: magnitude of correlation coefficients and
hierarchical regression. It is predicted that 1) significant negative correlations will
observed between measures of depression/apathy and executive/memory abilities and 2)
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depression and apathy will significantly predict level of executive and memory abilities
when entered as the first variable in hierarchical regression analyses.
It is hypothesized that apathy will be more strongly associated with executive
functioning than depressive symptoms. This hypothesis will also be examined in two
ways: magnitude of correlation coefficients and hierarchical regression. Using
correlational analyses and Hotelling’s t-test to compare correlations, it is predicted that
the correlation between apathy and executive functioning will be significantly greater
than the correlation between depression and executive functioning. Using hierarchical
regression, it is predicted that apathy will account for a significant proportion of added
variance in executive functioning scores over and above that accounted for by depression
alone, but that depression will not account for a significant proportion of added variance
in executive functioning scores over and above that accounted for by apathy alone.
Examination of additional findings from regression analyses will also afford
exploration of possible independent effects of apathy and depression on memory abilities
although hypotheses and predictions for this variable are less clear based on prior
literature.
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2. Method
Participants
Sixty-eight individuals (44 men, 24 women) diagnosed with idiopathic, nonfluctuating PD, ages 56-82, were included in the present study. Number of participants
required was determined by a priori power analysis using G-Power computer program
(Faul and Erdfelder, 1992). Sixty-eight participants was needed to yield a power of 0.80
given a medium effect size of d = 0.15. All participants were recruited from Movement
Disorder clinics of the University of South Florida Parkinson’s Disease Center of
Excellence and monthly PD support group meetings in the Tampa Bay area.
Patients with atypical Parkinson’s disease (i.e., known cause, including previous
exposure to toxins or atypical presentation of symptoms), early onset PD, or current or
past history of other neurological disorder, cardiac arrest, psychiatric disturbance (other
than depression or anxiety), or head injury with loss of consciousness were excluded
from participation. In addition, patients scoring below 24 on the Mini-Mental Status
Exam were excluded from participation. All patients were tested during the “on” phase,
when medication is effective and motor symptoms are reduced.

Measures
Beck Depression Inventory – II (BDI-II). The BDI-II (Beck, Steer, and Brown,
1996) is a 21-item self-report instrument intended to assess the existence and severity of
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depressive symptoms consistent with the depression criteria of the Diagnostic and
Statistical Manual of Mental Disorders – 4th Edition (DSM-IV; 1994). BDI-II items are
scored on a four-point Likert scale (0-3), with statements arranged to represent increasing
intensity of a particular symptom of depression. For the purposes of this study, the
following 13 items of the BDI-II will be used as a measure of depressive symptom
severity: Sadness, Pessimism, Past Failure, Loss of Pleasure, Guilty Feelings, Punishment
Feelings, Self-dislike, Self-criticalness, Suicidal Thoughts or Wishes, Crying,
Indecisiveness, Worthlessness, and Irritability (see Appendix A). This well-established
measure and has excellent reliability and validity. One-week test-retest reliability was
reported as r = 0.93 (Beck et al., 1996) and internal consistency across studies is excellent
(α = 0.89 – 0.94) (Dozois and Covin, 2004). Evidence for construct validity has stemmed
from several factor analyses (Dozois and Covin, 2004) and convergent, discriminant, and
content validity are well-supported (e.g., Beck et al, 1996; Osman et al., 1997; Dozois
and Covin, 2004).
Apathy Evaluation Scale – Self-Rating (AES-S) and Informant-Rating (AES-I).
The AES-S (Marin, 1991) is an 18-item self-rating scale that was developed to assess
apathetic symptoms within behavioral, cognitive, and emotional domains (see Appendix
B). Items are scored on a four point Likert scale (1 = “Not at all true”; 2 = “Slightly true”;
3 = “Somewhat true”; 4 = “Very true”) and scoring is arranged so that higher scores
represent greater apathy. This has been used in a number of clinical groups, including PD
and has been found to have good construct validity, internal consistency (α = 0.86) and
test-retest reliability (α = 0.76) (Marin et al., 1991). Multitrait-multimethod matrix
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procedures show support for convergent and discriminant validity (Marin, et al, 1991).
The AES-I is a parallel measure completed by a relative/spouse who has regular contact
with the research participant in order to provide an outside perspective. This was
administered when possible in order to investigate informant ratings, however, the AES-S
was used for analyses.
Mini Mental State Exam (MMSE). The MMSE (Folstein, Folstein, and McHugh,
1975) is an 11-item examination and the most widely used cognitive screening test.
Research provides widespread support for its validity in assessing global cognitive status.
Each item assesses one of the following domains: orientation to time, orientation to place,
registration, attention, recall, naming, repetition, comprehension, reading, writing, and
drawing. Patients scoring less than 24 will be excluded from the study to avoid confounds
of significant cognitive impairment, which may affect patients’ ability to validly
complete self-report measures.
Wisconsin Card Sorting Test-64 (WCST-64). The WCST-64 (Kongs, Thompson,
Iverson, and Heaton, 2000) is a shortened version of the Wisconsin Card Sorting Test,
Revised and Expanded (WCST; Heaton, Chelune, Talley, Kay, and Curtiss, 1993), one of
the most widely used measures of executive functioning. The test provides detailed
feedback regarding specific aspects of problem-solving abilities, such as inefficient initial
conceptualization, perseveration, failure to maintain a cognitive set, and inefficient
learning. In this task, subjects are required to match 64 cards to one of four target cards.
Matching rules are color, shape/form, or number of symbols. Subjects infer these rules
from feedback about whether the match was correct, which is provided by the tester
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immediately following the match. After ten consecutive correct matches, the tester
changes the rule without preannouncement. The Number of Categories Completed score
will be selected for the present analysis as it reflects the ability to shift set from one
activity to the next. Past research shows that PD patients are particularly sensitive to this
type of task (eg., Cools, Barker, Sahakian, and Robbins, 2001). The WCST-64 has
excellent interscorer and intrascorer reliability (0.88-0.93 and 0.91-0.96, respectively)
(Paolo et al., 1996; Axelrod, Goldman, and Woodard, 1992), and has demonstrated
sensitivity to executive impairment in PD, Alzheimers disease, and in individuals who
have suffered frontal lobe injury (e.g., Paolo et al., 1996; Robinson, Heaton, Lehman, and
Stilson, 1980).
Hopkins Verbal Learning Test-Revised (HVLT-R). The HVLT-R (Benedict,
Schretlen, Groninger, Brandt, 1998) is a verbal learning and memory test that consists of
a list of 12 words, each belonging to one of three semantic categories. There are three
immediate memory trials, one delayed recall trial (20-25 minutes after completion of the
third immediate memory trial), and a recognition trial. The Total Recall score, which is
the sum of the three immediate memory trials, will be selected for the present analysis
because prior research shows that PD patients have more pronounced impairments on
immediate memory tasks compared to delayed memory tasks (Sagar et al., 1988).
Literature supports the reliability of the HVLT-R (e.g., six-week test-retest reliability for
Total Recall is 0.74 in healthy elderly) (Benedict et al., 1998) as well as construct
discriminative, and predictive validity. Shapiro and colleagues (1999) demonstrated that
HVLT Total Recall was correlated with a prose verbal memory test (i.e., Logical
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Memory) at r = 0.75, showed 95% sensitivity and 83% specificity, had a positive
predictive value of 0.84, and a negative predictive value of 0.94.).

Procedure
Eligible participants were recruited from the Department of Neurology and
Movement Disorders Clinics at the University of South Florida and from support group
meetings in the Tampa Bay area. Patients were invited to participate by clinic
neurologists during regular patient visits or by a research assistant on the present study.
Diagnosis and staging of PD was determined by board-certified neurologists using the
Hoehn and Yahr scale (1967), a standard staging scale commonly used in PD research.
After giving informed consent, participants were screened with the MMSE to
ensure that they met basic cognitive requirements. Those with an MMSE score below 24
were excluded from further participation. Next, included participants were asked to
complete a series of self-report measures to determine their affective status. Some
participants completed these questionnaires after their appointment and returned them by
mail within one week of participation. A memory test was then administered by the
primary investigator, followed by a test of executive functioning.

Statistical Analyses
Two approaches were used to examine the relationship between cognitive
functioning (memory and executive functioning) and psychological symptom severity
(depression and apathy) in the present study: (1) correlation coefficients, and (2)
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regression analyses. First, correlation coefficients were calculated between psychological
and cognitive variables, revealing a total of four correlation coefficients (i.e., 1. executive
function and depression, 2. executive function and apathy, 3. memory and depression, 4.
memory and apathy).
Hierarchical regression analyses were then conducted to compare the degree of
influence that depression and apathy have on cognitive impairment. Executive function
and memory served as criterion variables and were evaluated independently. In the two
hierarchical regression analyses of executive ability, the independent effects of depression
and apathy on executive functioning were assessed. In the first hierarchical regression
analysis, the selected items of the BDI-II were entered to account for the influence of
depressive symptoms. Finally, the AES-S was entered, leaving a final change in R2 that
reflects the amount of variance in executive functioning that is accounted for by apathy
above and beyond the influence of depression (i.e., while controlling for the effects of
depression). In the second hierarchical regression analysis of executive ability, the AES-S
was entered to account for the influence of apathy symptoms. Finally, the selected items
of the BDI-II were entered, leaving a final change in R2 that reflects the amount of
variance in executive functioning that is accounted for by depression above and beyond
the influence of apathy (i.e., while controlling for the effects of apathy).
The same two hierarchical regression analyses were repeated to assess the
independent influence of depression and apathy on memory. The final R2 in both
hierarchical regression analyses reflects the amount of variance in memory that is
accounted for by the independent influence of depression or apathy.
33

3. Results
Diagnostics
SPSS 15.0 for Windows was used to manage and analyze data. Prior to
conducting analyses to investigate the above stated hypotheses, data point distributions
were examined for significant departures from normality and data was examined to
ascertain that regression assumptions were met. Examination of boxplots and
standardized residuals confirmed that data points of interest fell within acceptable limits
(+/- 3 standard deviations from the mean) for analysis. Cook’s d (range: 0.000 – 0.218),
hat values (range: 0.004 – 0.174), and Mahalanobis distance (range: 0-.256 – 11.672)
values revealed that no individual cases were producing undue influence on the
regression model. Examination of boxplots and descriptive statistics confirmed the
absence of skewness and kurtosis among the variables. Scatterplots of regression
standardized residuals and predicted values verified the assumptions of homoscedasticity
and linearity. The inspection of VIF (all values ≤ 1.466) and tolerance statistics (all
values ≥ 0.682), eigenvalues and variance proportions, as well as correlation coefficients
between predictors (r < 0.60) revealed that the assumption of no multicollinearity was
met. Durbin-Watson statistic values (range: 1.729 – 2.545) fell within acceptable limits,
supporting the assumption of independent errors.
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Descriptives
Data was obtained from 68 Parkinson’s disease patients between the ages of 56
and 82 years (mean = 69.96, SD = 7.03). Subjects were majority male (n = 45, 66.2%)
and Caucasian (n = 63; 92.6%), Education level ranged from 12-22 years (mean = 15.74,
SD = 2.62). All patients were in the mild to moderate stages of diseases (Hoehn and Yahr
Stages 1-3). Depression severity ranged from no symptoms of depression to moderate
levels and apathy severity ranged from no apathy symptoms to severe levels. Cognitive
performance ranged from better than expected to severe impairment. A summary of
demographic, clinical, and experimental variables from this sample is provided in Tables
1 and 2.

Table 1: Summary of demographic and clinical characteristics

Age

Range
56 - 82

Mean (SD)
69.96 (7.03)

Years of education

12 - 22

15.74 (2.62)

Disease duration
(yrs)

<1 - 24

7.07 (4.96)

n

%

Gender
Male
Female

45
23

66.2 %
33.8 %

Ethnicity
White
Black
Hispanic

63
1
4

92.6 %
1.5 %
5.9 %
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Table 1 (Continued)
n

%

Stage of disease
1
2
3
data not obtained

15
33
9
11

22.1 %
48.5 %
13.2 %
16.2 %

Side of onset
R
L
data not obtained

32
31
5

47.1 %
45.6 %
7.4 %

Table 2: Summary of mood and cognitive scores including age-adjusted T-scores

Depression
(21-item BDI)

Raw scores
Range
Mean
(SD)
0-23
10.62
(5.26)

T-scores
Range
Mean
(SD)
37-76
44.75
(9.16)

Depression
(13-item BDI)

0-14

4.10
(3.49)

--

--

Apathy
(AES-S)

18-50

30.29
(7.51)

34-84

46.57
(11.73)

Imm Memory*
(HVLT Total Recall)

8-33

21.31
(5.84)

20-70

43.34
(10.97)

Executive Fx**
(WCST Categories)

0-5

2.06
(1.71)

17-64

38.75
(10.06)

*

T-scores adjusted for age and education
T-scores adjusted for age

**
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Correlation analyses were used to evaluate the relationships between demographic
and clinical variables (i.e., age, years of education, disease duration), and experimental
variables (i.e., depression, apathy, memory, executive functioning) (see Table 3). Raw
scores were used in all correlation and regression analyses. Increasing age was
significantly associated with decreases in memory and executive performance (r = 0.279, p < 0.01 and r = -0.312, p < 0.05, respectively). Years of education and disease
duration were not associated with cognitive performance.

Table 3: Correlations

.233t

Memory
(HVLT
Total Recall)
-0.279*

Executive Fx
(WCST
Categories)
-0.312**

0.086ns

0.150ns

-0.026ns

0.053ns

-0.096ns

-0.061ns

0.111ns

0.158ns

Depression
(13-item
BDI)
0.189ns

Apathy
(AES-S)

Age

Depression
(21-item
BDI)
.303**

Education

0.022ns

Disease
duration
*
p<0.05

-0.056ns
**

p<0.01

t

trend, p<0.10

ns

not significant, p>0.10

Frequencies of apathy and depression
The frequency of apathy, using AES-S ≥ 38 as representative of clinically
significant elevations in apathy (Pluck and Brown, 2002; Rabkin, Ferrando, van Gorp, et
al., 2000), was 20%. This rate appears to be lower than reported frequencies of apathy in
other studies using self-ratings (Kirsch-Darrow, Fernandez, Marsiske, Okun, and Bowers,
2006) and may be due to measurement differences or to the restricted range of disease
severity in the present sample, as all of our participants were in the mild to moderate
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stages of disease. When using the more commonly used BDI cut-off score of 10, the
frequency of mild or greater depressive symptoms was 52%, which is similar to
percentages reported in previous studies (e.g., Brooks and Doder, 2001; Cummings,
1992). When using a cut-off score of 16/18, suggested for more accurate identification of
diagnosable depression in mild to moderate PD patients (Silberman et al., 2006;
Leentjens, Verhey, Luijckx, and Troost, 2000), the frequency of depression was 13.3%.
The majority of patients with depression severity scores above this cut-off were in the
mild range and fewer fell within the moderate range.
Based on AES and BDI cut-off scores of 38 and 18, respectively, patients in
present study were assigned to four categories for frequency analyses (i.e., apathy-only,
depression-only, apathy and depression, and no apathy or depression). The majority of
patients (72.1%) were classified as neither apathetic nor depressed, whereas 14.7% of
patients were classified as apathy-only, 7.4% as depression-only, and 5.9% as apathy and
depression.

Findings related to Hypothesis #1
To investigate the hypothesis that increased levels of depression and apathy will
be associated with decreased performance on measures of executive and memory
abilities, four correlation coefficients and four simple regressions were examined.
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Correlations
Table 4 displays the results of correlation analyses. Increases in depressive
symptoms were associated with decreases in memory scores (r = -0.273, p < 0.05) but
were not significantly associated with executive functioning. Increases in apathy
symptoms were associated with decreases in both memory (r = -0.331, p < 0.01) and
executive functioning (r = -0.305, p < 0.05). Apathy and depressive symptoms were
positively and moderately correlated (r = 0.548, p < 0.01).

Table 4: Correlations between mood and cognitive variables
Variable

Depression
(13-item BDI)

Depression

1.000

Apathy

.548**

1.000

Memory

-.273*

-.331**

Executive Fx
p<0.05

*

**

-.141ns
p<0.01

ns

Apathy
(AES-S)

Memory
(HVLT Total
Recall)

Executive Fx
(WCST
Categories)

1.000

-.305*
.478**
not significant, p=.251

1.000

Regressions
These relationships are corroborated by four simple regression analyses, in which
level of depressive symptoms or apathy symptoms were entered as the sole independent
variable (IV) and memory or executive functioning was entered as the sole dependent
variable (DV) (see Table 5). First, it was found that level of depressive symptoms
significantly predicted memory scores (ß = -.273, t(66) = -2.309, p < 0.05), with 7.5% of
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the variance explained (R2 = .075, F(1,66) = 5.331, p < 0.05). Second, level of depressive
symptoms did not significantly predict executive functioning scores, as evidenced by a
non-significant ß value (ß not significantly different from 0) and a non-significant F
value. The third simple regression revealed that level of apathy symptoms significantly
predicted memory scores (ß = -.331, t(66) = -2.849, p < 0.01), with 10.9% of the variance
explained (R2 = .109, F(1,66) = 8.115, p < 0.01). The final simple regression revealed
that level of apathy significantly predicted scores of executive functioning (ß = -.305,
t(66) = -2.602, p < 0.05), with 9.3% of the variance explained (R2 = .093, F(1,66) =
6.770, p < 0.05).

Table 5: Simple regression analyses
Criterion
Memory

Predictor
Depression

SB
-.273

T
-2.309

Sig T
.024*

R2
.075

F
5.331

Sig F
.024*

Exec. Fx

Depression

-.141

-1.158

.251

.020

1.341

.251

Memory

Apathy

-.331

-2.849 .006**

.109

8.115

.006**

.011*

.093

6.770

.011*

Exec. Fx. Apathy
-.305
* p<0.05
**p<0.01
SB=Standardized Beta

-2.602

Findings related to Hypothesis #2
To investigate the hypothesis that apathy will be more strongly associated with
executive functioning than depressive symptoms, two correlation coefficients (1.
correlation between executive functioning and depression, and 2. correlation between
executive functioning and apathy) and two hierarchical regressions were examined.
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Correlations
As mentioned above (see Table 4), executive functioning was significantly
correlated with apathy (r = -.305, p < 0.05), but not with depression (r = -.141, p = .251).
Due to the non-significant correlation between executive functioning and apathy, the
proposed Hotelling’s t-test to compare correlations was not conducted.

Regressions
Examination of the first hierarchical regression analysis reveals the influence of
apathy on executive functioning scores while controlling for the influence of depressive
symptoms (see Table 6-A). In this analysis, depression (IV) is entered in the regression
first and apathy (IV) is entered second to assess whether apathy contributed unique
variance in accounting for executive performance above and beyond that of depressive
symptoms. As noted above, depressive symptoms did not account for any significant
portion variance in executive performance when entered alone. However, the addition of
apathy reveals that apathy accounts for 9.4% of the variance in executive performance,
with a significant change in the value of the F-test with the addition of this variable (R2 =
.094, p <0.05; F(1,65) = 3.372, p < 0.05).
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Table 6-A: Hierarchical regression analyses related to executive functioning
Unstandard.
Predictor
beta
SE
SB
R2
(Constant)
4.229
.875
--Depression
.018
.069 .037 .020
Apathy
-.074
.032 -.325 .094
* p<0.05
**p<0.01
SE=Standard Error; SB=Standardized Beta

Criterion
Exec. Fx

R2Ì
-.020
.074

FÌ
-1.341
5.315

Sig FÌ
-.251
.024*

Age effects. Due to the fact that age was significantly correlated with the DV
(executive functioning) and was approaching significance (p = 0.056) when correlated
with one of the IVs (apathy), age was entered into regression equations first in order to
control for its influence on executive functioning (see Table 6-B). Following the entry of
age, apathy was entered to assess its unique influence on executive functioning while
controlling for age. Depression was not entered into this model due to the nonsignificant
relationship between depression and executive functioning described above, and to the
potential unfavorable effect that entering three predictors may have on power. Analyses
revealed that age accounted for 9.7% of the variance in executive performance and
apathy accounted for an additional 5.7% of the variance in executive performance.

Table 6-B: Hierarchical regression analyses related to executive functioning, controlling
for age
Unstandard.
beta
SE
SB
R2
Predictor
(Constant)
8.245
2.029
--Age
-.063
.029 -.258 .097
Depression
.029
.067 .060 .104
Apathy
-.063
.032 -.278 .157
* p<0.05
**p<0.01
SE=Standard Error; SB=Standardized Beta

Criterion
Exec. Fx
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R2Ì
-.097
.007
.053

FÌ
-7.095
.510
3.989

Sig FÌ
-.010**
.478
.050*

Ancillary Analyses
Exploration of the Influence of Apathy and Depression on Memory
In order to explore the independent effects of apathy and depression on memory
abilities, two additional hierarchical regressions were conducted and examined.
Examination of the first hierarchical regression analysis reveals the influence of apathy
on memory scores while controlling for the influence of depressive symptoms (see Table
7-A). In this analysis, depression (IV) is entered in the regression first and apathy (IV) is
entered second to assess whether apathy contributed unique variance in accounting for
memory performance above and beyond that of depressive symptoms. As noted
previously, depression accounts for 7.5% of the variance in memory scores when entered
first into the regression. The addition of apathy reveals that apathy accounts for an
additional 4.7% of unique variance in memory performance, as evidenced by a change in
the value of the F-test that approaches significance with the addition of this variable (R2
= .122; R2 change = .047, p = .067; F(1,65) = 4.499, p < .05).
For exploratory purposes, a second regression analysis was conducted to evaluate
the influence of depressive symptoms on memory performance while controlling for the
influence of apathy (see Table 7-A). In this analysis, apathy was entered in the first step
and depression was entered second to assess whether depression contributed unique
variance in accounting for memory performance above and beyond that of apathy
symptoms. As noted previously, apathy accounts for 10.9% of the variance in memory
scores when entered first into the regression. The addition of depression reveals that
depression does not account for any additional or unique variance in memory scores over
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and above that of apathy, as evidenced by a non-significant ß value (ß not significantly
different from 0) and a non-significant F value.

Table 7-A: Hierarchical regression analyses related to immediate memory
Unstandard.
Criterion Predictor
beta
SE
SB
Memory (Constant)
28.308 2.943
-Depression
-.220
.232 -.132
Apathy
-.201
.108 -.259
Memory (Constant)
28.308 2.943
-Apathy
-.201
.108 -.259
Depression
-.220
.232 -.132
t
* p<0.05
**p<0.01
trend, p<0.10
SE=Standard Error; SB=Standardized Beta

R2
-.075
.122
-.109
.122

R2Ì
-.075
.047
-.109
.012

FÌ Sig FÌ
--5.331 .024*
3.467 .067t
--3.115 .006**
.896
.347

Age effects. Due to the fact that age was significantly correlated to the DV
(memory) and was approaching significance (p = 0.056) when correlated with one of the
IVs (apathy), age was entered into regression equations first in order to control for its
effect on memory (see Table 7-B). Following the entry of age, depression was entered
second and apathy was entered last. Analyses revealed that age accounted for 7.8% of the
variance in memory performance (p = 0.02), depression accounted for an additional 5.1%
of the variance in memory performance (p = 0.057), and apathy no longer accounted for a
significant portion of additional variance in memory performance (R2 change = 3.3%, p =
0.116). Considering the p-value associated with the entry of apathy last (p = 0.116), it is
quite possible that the reduction in power caused by entering a third predictor variable
into the model (power = 0.75) may have resulted in the inability to adequately identify a
significant R2 change when apathy was entered as the third variable. Interestingly, when
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apathy was entered into the regression analysis before depression, level of apathy
symptoms significantly accounted for an additional 7.5% of the variance in memory
performance (p = 0.02), after accounting for the influence of age. In this order of
operations, level of depressive symptoms no longer accounted for a significant portion of
additional variance in memory performance (R2 change = 0.9%, p = 0.411), consistent
with the two-predictor model described previously, which did not include age in the
model.

Table 7-B: Hierarchical regression analyses related to immediate memory, controlling for
age
Unstandard.
Criterion Predictor
beta
SE
SB
Memory (Constant)
39.261 6.907
-Age
-.171
.098 -.206
Depression
-.190
.229 -.114
Apathy
-.172
.108 -.221
Memory (Constant)
39.261 6.907
-Age
-.171
.098 -.206
Apathy
-.172
.229 -.221
Depression
-.190
.108 -.114
t
* p<0.05
**p<0.01
trend, p<0.08
SE=Standard Error; SB=Standardized Beta

R2
-.078
.128
.162
-.078
.153
.162

R2Ì
-.078
.051
.033
-.078
.075
.009

FÌ
-5.573
3.767
2.534
-5.573
5.733
.685

Sig FÌ
-.021*
.057t
.116
-.021*
.020*
.411

Use of the 21-item versus 13-item Version of the BDI-II
All analyses described above included an altered version of the BDI-II (13-item
BDI) as the measure of total depressive symptoms, which excluded somatic and apathyrelated items in order to reduce potential confounds of these items on the measure of
depression. Comparisons were made between regression analyses that used the 13-item
45

BDI-II and the full 21-item BDI-II in order to assess whether the decision whether or not
to include somatic and apathy-related items in the measurement of depressive symptoms
would result in disparate findings. Notably, when the full 21-item BDI-II was included in
the regression analyses (i.e., 1. memory regressed on apathy and depression, 2. executive
functioning regressed on depression and apathy) in place of the 13-item version, results
were comparable. In addition, there was little difference in the correlations between
apathy and depression severity regardless of whether the full 21-item version or the
altered 13-item version was used in the analysis (r = 0.548 versus r = 0.563,
respectively). These findings suggest that the omission of “overlapping” somatic and
apathy-related items from the BDI for the purpose of measuring symptoms unique to
depression may not be beneficial.

Use of Informant-Ratings versus Self-Ratings of Apathy
Comparisons were made between regression analyses that used the AES selfrating form (AES-S) and the informant-rating form (AES-I) in order to assess whether the
source of this information would have an effect on the findings. In the regression
analyses that included executive functioning as the DV, results were comparable
regardless of whether the AES-S or AES-I was used. In the regression analyses that
included memory as the DV, results were also comparable with the use of the AES-I
except that the added influence of apathy over and above that of depression reached full
statistical significance (p < 0.05) as opposed to being a trend.
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4. Discussion
The purpose of the present study was to examine the independent influence of
depression and apathy on immediate memory and executive functioning in PD patients
using sensitive measures of cognitive performance as well as rating scales that assess
symptoms unique to depression and apathy. Due to the potential confounds of including
somatic and apathy-related items in the measurement of depression severity, only BDI-II
items corresponding to the cognitive/affective scale were retained (e.g., sadness,
pessimism, sense of failure, etc.), with the exception of the item related to lack of interest
due to its overlap with apathy. In other words, all somatic and apathy-related items from
the full BDI-II were eliminated in order to create the modified version of the BDI-II used
in the present study. Further, the AES was chosen to measure apathy severity due to its
purported ability to discriminate between apathy and depression.

Effects of Apathy and Depression on Memory and Executive Ability
In the present study, two hypotheses were investigated. First, it was hypothesized
that increased levels of depressive symptoms and increased levels of apathy would be
associated with decreased performance on measures of executive and memory abilities.
In support of this hypothesis, apathy negatively correlated with memory and executive
functioning in correlation analyses and level of apathy predicted level of memory and
executive functioning in regression analyses. The hypothesis was further supported in
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that depression negatively correlated with memory performance in correlation analyses
and level of depression predicted level of memory in regression analyses. Surprisingly,
however, a relationship between depression and executive functioning was not identified.
The correlation between level of depressive symptoms and executive functioning was not
significant. While it was predicted that the magnitude of the relationship between apathy
and executive functioning would be significantly larger than that of the relationship
between depression and executive functioning, the lack of a significant correlation
between depression and executive function was unexpected. Notably, the lack of
association between these variables remained when the full 21-item BDI-II was included
in secondary analyses, demonstrating that the lack of relationship between depression
severity and executive functioning was not explained by the exclusion of somatic and
apathy-related items or by the consequent reduction in range of scores.

Unique Effects of Apathy and Depression on Executive Function
Second, it was hypothesized that apathy would be more strongly associated with
executive functioning than depressive symptoms as demonstrated by the magnitude of the
correlation coefficients and by a significant R2 change when apathy was entered last in a
hierarchical regression analysis. This hypothesis was supported. Increases in apathy, but
not depression, were significantly associated with decreases in executive performance.
Hierarchical regression analyses revealed that apathy, and not depression, accounted for a
significant proportion of added variance in executive functioning. When controlling for
age, this finding remained.
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It is possible that the relationship between depression and executive function may
be a small effect, and that the present study did not have an adequate number of
participants, and hence power, to detect that relationship. While the number of
participants in the present study (n = 68) is adequate for detecting a medium effect size
with power of 0.80, this would not have been enough subjects to detect a small effect.
Alternatively, using a shortened version of the BDI-II may have restricted the range of
scores on this measure of depressive symptoms. However, this is unlikely for a couple of
reasons. First, the lack of association remained when using the full version of the BDI-II
as when using the shortened, modified version. Second, a relationship was identified
between level of depressive symptoms (i.e., as measured using the shortened BDI-II) and
memory, indicating that the memory analyses were not hindered by restriction of range.
Regardless, the finding that the relationship between depression and executive function is
not significant in the present study, but that the relationship between apathy and
executive function is significant, supports the notion that apathy has a greater influence
than depression on executive impairment in patients with Parkinson’s disease.
The present findings are consistent with other studies reporting similar results.
Pluck and Brown (2002) found that apathy, but not depression, was associated with
deficits on three measures of executive functioning (i.e., category fluency, Stroop ColorWord test, and WCST). Isella and colleagues (2002) found that PD patients with highapathy showed significantly greater impairment in executive functioning [i.e., Executive
Interview (EXIT), letter fluency and category fluency] when compared to low- and
moderate-apathy groups. Significant correlations were identified between apathy and
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executive functioning while depression was not significantly associated with apathy or
any cognitive abilities measured. Similarly, Aarsland and colleagues (1999) identified a
significant association between executive functioning and apathy but not between
executive functioning and depression or between apathy and depression.

Unique Effects of Apathy and Depression on Memory
Finally, exploratory analyses were conducted to investigate the possible
independent effects of apathy and depression on immediate memory abilities. As stated
above, levels of both apathy and depressive symptoms were similarly correlated with
memory performance. Hierarchical regression analyses were used to investigate the
degree of influence that apathy has on memory performance when controlling for
depression and the degree of influence that depression has on memory performance when
controlling for apathy. Our findings suggest that while depression does not predict
memory scores over and above that of apathy, apathy revealed a strong trend to predict
memory over and above that of depression (i.e., p = .067).
When controlling for age, the findings became less clear. It is important to note
that by choosing to investigate the effects of apathy and depression on memory while
controlling for age, power was reduced to 0.75 due to the addition of a third independent
variable (i.e., age) into the regression equation. A closer look at the p-values associated
with entering either depression or apathy as the third variable (refer to Table 7-B) reveals
that when age is controlled for, apathy likely remains as a significant predictor of
memory scores over and above that of depression (p = .116). In contrast, it is unlikely
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that depression is a significant predictor of memory scores over and above that of apathy
(p = .411). A larger sample is needed to test whether this is, in fact, accurate, since there
was insufficient power to investigate the influence of three independent variables given
the sample size in this investigation. An alternative explanation for this finding is that,
despite our attempts to use measures that assess non-shared aspects of apathy and nonshared aspects of depression, our measurement did not fully discriminate. This raises
question regarding the construct validity of the scales used and begs further investigation
into definitions and assessments of apathy.

Conclusion
Overall, the findings of the present study suggest that apathy and depression may
exert unique effects on memory and executive function. These findings provide support
for the notion of apathy and depression as discernable constructs. First, apathy and
depression were differentially related to cognitive performance, most strongly in the
domain of executive functioning. Second, the frequencies of clinical elevations of apathy
and depression in the present sample also support the notion that apathy and depression
can be considered as distinguishable constructs, with clinically elevated apathy symptoms
existing in the absence of clinically elevated depressive symptoms. The presence of
clinically elevated apathy in the absence of depression has been even more convincingly
and consistently in Alzheimers disease, frontotemporal dementia, progressive
supranuclear palsy, and basal ganglia stroke (e.g., Levy et al., 1998; Starkstein et al.,
2005).
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While unique aspects of depression and apathy may explain their differential
influence on executive functioning, shared factors may underlie their relationship with
memory. Potential shared mechanisms may include frontostriatal circuitry, reduced
processing speed, anergia, avolition, and the emotional concomitants of apathy (e.g.,
anhedonia). While most of the apathy literature is consistent in defining apathy by
behavioral and cognitive dimensions, opinions differ on whether definitions should
include an emotion dimension (Starkstein and Leentjens, 2007). According to a
preliminary study of patients with dementia, anhedonia is rarely reported in patients who
report apathy but no depression, suggesting that anhedonia may be more characteristic of
depression than apathy (SE Starkstein, personal communication; as cited in Starkstein
and Leentjens, 2007).

Theoretical Implications
Differentiation of apathy and depression and understanding their independent
effects has several implications both for clinical treatment and for scientific pursuit. First,
apathy appears to be negatively associated with cognitive functioning, daily functioning,
and caregiver burden and distress (van Reekum et al., 2005). Secondly, apathy has been
associated with increased morbidity and mortality. Apathetic patients devote less
attention and time to self-care, which can result in medical complications. Additionally, it
may interfere with treatment response and medication compliance and has been
associated with increased mortality and financial burden (Stephenson, 2005; van Reekum
et al., 2005).
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Further, due to the absence of reported or exhibited distress, patients suffering
from apathy are often overlooked by the health care system. There is currently a bias in
health care favoring diagnosing depression (Schulman, 2000). Cognizance of apathy in
patients seeking health care services may help to prevent false positive diagnoses of
depression and may increase efficiency in timely and adequate treatment of patients
experiencing apathy and not depression. Additionally, making caregivers aware of the
prevalence of apathy in Parkinson’s disease, among other neuropsychiatric or neurologic
diseases, may help them understand that related behaviors are not due to insolence or
laziness but, rather, to a disease-related neurologic changes.
Identification of apathy may be improved by the inclusion of apathy in psychiatric
classification systems. Currently, apathy is underrepresented in such classification
systems. Apathy is not referenced in the ICD-10 (WHO, 1993) and is only mentioned
specifically in relation to four disorders of the DSM-IV (APA, 1994), with no inclusion
of the term “apathy” in the DSM-IV glossary. Discussion regarding differential diagnosis
and on whether apathy should appear as a stand-alone disorder in the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) has begun (Stephenson,
2005). If not included as a stand-alone disorder, potential improvements of the status of
apathy, including clarifying the definition of apathy, adding apathy to the glossary of the
DSM, or creating a reference to help direct clinicians to the range of disorders commonly
associated with apathy, are being considered by DSM-IV Editor, Michael B. First, MD
(Stephenson, 2005).
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If appropriately identified, preliminary research suggests that symptoms of apathy
may be medically or behaviorally treated independently of depressive symptoms. For
example, Weitzner and colleagues (2005) described four cases of pituitary disease
patients who were diagnosed and medically treated for depression but showed little
response to treatment. When the diagnosis of apathy syndrome was considered and
treatment with methylphenidate was implemented, the patients’ condition improved
subjectively and on objective cognitive tasks. Further, Hoehn-Saric, Lipsey, and McLeod
(1990) found that apathy and indifference followed treatment with select antidepressant
serotonin-reuptake-inhibitors. Notably, these were not randomly, controlled medication
trials, which would be a great benefit to the apathy treatment literature.
Behavioral treatments may also provide benefit to patients experiencing
disruptive levels of apathy. Boyle and Malloy (2004) have suggested that caregivers may
be able to play an important role in behavioral training programs aimed at reducing
apathy in patients with Alzheimer’s disease. By definition, apathy involves the lack of
motivation and initiation. Caregivers may promote behavioral activation by helping
patients initiate goal-directed behaviors, increasing their involvement in pleasant
activities, and providing increased structure for activities.
Future research elucidating the effectiveness of caregiver-involved behavioral
interventions, as well as randomized controlled medication trials, on patients with
elevated levels of apathy is warranted. In addition, future studies aimed at understanding
the neural underpinnings of depression and apathy may help guide more effective choices
of pharmacological and/or behavioral management of these symptoms. Further
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investigation into the relationship between apathy and fluctuating on/off periods in PD
patients, in which levels of dopamine are adequate or limited in the brain, may provide
interesting information regarding the underlying neurotransmitter effects.
Differentiation of apathy and depression has robust implications for the
advancement of psychological science and patient care. The utility of investigating
symptoms of apathy and depression, as opposed to solely clinical diagnoses, is evident in
that even some level of symptomatic apathy and depression appears to influence
efficiency of patients’ cognitive abilities. A focus on apathy symptoms in patients may
optimize treatment approaches, improve patients’ daily functioning, increase
independence, and result in an improved quality of life for both patients and their
caregivers.
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Appendix A: Beck Depression Inventory – II
(Note: Items used for the 13-item modified version are highlighted)
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Appendix B: Apathy Evaluation Scale – Self-Rating form

For each question, circle the answer that best describes your
thoughts, feelings and actions during the past 4 weeks.
1. I am interested in things.
Not at All
0 items
1

Slightly
1-2 items
2

Somewhat
2-3 items
3

Very
3 or more items
4

Somewhat
2-3 items
3

Very
3 or more items
4

2. I get things done during the day.
Not at All
0 items
1

Slightly
1-2 items
2

3. Getting things started on my own is important to me.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

4. I am interested in having new experiences.
Not at All
0 items
1

Slightly
1-2 items
2

Somewhat
2-3 items
3

Very
3 or more items
4

Somewhat
2-3 items
3

Very
3 or more items
4

5. I am interested in learning new things.
Not at All
0 items
1

Slightly
1-2 items
2
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6. I put little effort into anything.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

Somewhat
Characteristic
3

A Lot
Characteristic
4

7. I approach life with intensity.
Not at All
Characteristic
1

Slightly
Characteristic
2

8. Seeing a job through to the end is important to me.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

9. I spend time doing things that interest me.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

10. Someone has to tell me what to do each day.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

11. I am less concerned about my problems than I should be.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

Slightly
1-2 items
2

Somewhat
2-3 items
3

Very
3 or more items
4

12. I have friends.
Not at All
0 items
1
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13. Getting together with friends is important to me.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

14. When something good happens, I get excited.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

15. I have an accurate understanding of my problems.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

16. Getting things done during the day is important to me.
Not at All
Characteristic
1

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

Slightly
Characteristic
2

Somewhat
Characteristic
3

A Lot
Characteristic
4

17. I have initiative.
Not at All
Characteristic
1
18. I have motivation.
Not at All
Characteristic
1
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